Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen (Q36347559)

13 August 2017

Therapy of murine leukemia with monoclonal antibody against a normal differentiation antigen (English)

1 reference

13 August 2017

1 reference

C C Badger

1

1 reference

13 August 2017

I D Bernstein

series ordinal

2

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 March 1983

1 reference

Journal of Experimental Medicine

13 August 2017

1 reference

13 August 2017

157

1 reference

13 August 2017

3

1 reference

13 August 2017

828-842

1 reference

Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Serotherapy of malignant disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Selective killing of normal or neoplastic B cells by antibodies coupled to the A chain of ricin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Continuous cultures of fused cells secreting antibody of predefined specificity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Antibody-mediated suppression of grafted lymphoma. IV. Influence of time of tumor residency in vivo and tumor size upon the effectiveness of suppression by syngeneic antibody

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Oncornaviruses produced by murine leukemia cells in culture

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-Sepharose

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Suppression of antibody-sensitized tumor cells by macrophages: insufficient supply or activation of macrophages within large tumors

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2186954

Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody

29 June 2018

1 reference

12 December 2020

Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin

1 reference

12 December 2020

Anti-transferrin receptor monoclonal antibody and toxin–antibody conjugates affect growth of human tumour cells

1 reference

12 December 2020

Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum

1 reference

12 December 2020

Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo

1 reference

12 December 2020

Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody

1 reference

12 December 2020

Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells

1 reference

12 December 2020

Immunologic control of the ascites form of murine adenocarcinoma 755. III. Efficacy of serum therapy is controlled by a single genetic locus

1 reference

12 December 2020

Immunologic control of the ascites form of murine adenocarcinoma 755. V. Antibody-directed macrophages mediate tumor cell destruction

1 reference

12 December 2020

Immunotherapy of murine leukemias by monoclonal antibody. I. Effect of passively administered antibody on growth of transplanted tumor cells

1 reference

12 December 2020

Identifiers

DOI

10.1084/JEM.157.3.828

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

6403649

1 reference